polatuzumab in diffuse large b-cell lymphoma
Published 10 months ago • 421 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
24:57
how to treat diffuse large b-cell lymphoma (dlbcl) - dr. carla casulo
-
21:26
polatuzumab fda approval in dlbcl (polarix) & swog s1826 nivo vs. bv in hodgkin's lymphoma
-
0:46
dlbcl prognosis & management in front-line settings #oncology #lungcancer #cancer #2023
-
43:40
polatuzumab vedotin in previouslyuntreated diffuse large b-cell lymphoma.
-
0:55
results of polarix trial #oncology #cancer #2023
-
43:40
polatuzumab vedotin in previouslyuntreated diffuse large b-cell lymphoma
-
0:41
results of swog s1826 study, showing nivo-avd better than bv-avd in hodgkin's lymphoma patients
-
0:55
swog s1826 study design discussion in hodgkin's lymphoma patients #oncology #cancer #2023
-
3:12
polarix: polatuzumab vedotin and r-chp superior to r-chop in dlbcl
-
2:07
dr. hou on polatuzumab vedotin in dlbcl
-
2:00
polatuzumab vedotin and car t-cell therapy for diffuse large b-cell lymphoma
-
4:59
a breakthrough therapy: polatuzumab vedotin plus br for r/r dlbcl
-
2:28
improving outcomes for r/r dlbcl with polatuzumab vedotin
-
1:35
dr. pagel on the implications of polatuzumab vedotin approval in dlbcl
-
4:47
the polarix trial: initial therapy of diffuse large b-cell lymphoma
-
4:56
catherine diefenbach: polatuzumab vedotin for follicular lymphoma
-
1:15
polatuzumab vedotin combined with chemotherapy in untreated large b-cell lymphoma
-
2:01
will newer therapies be curative for diffuse large b-cell lymphoma patients?
-
4:39
treatment alternatives to chemotherapy in r/r dlbcl